New Research Promises More Effective Treatment for Millions of Women and Huge NHS Cost Savings

BRISTOL, England, January 18 - New research published in the British Journal of Urology proposes
improvements to the NHS-recommended treatment for stress incontinence (SUI).

This is welcome news for millions of women who can expect quicker relief
from their distressing symptoms, as well as for NHS bosses who can deal with
this major health problem more effectively.

The author of the article, Professor Marcus Drake of the Bristol Urology
Institute, highlights fundamental weaknesses in the current treatment
recommended by NICE - pelvic floor muscle exercise (PFME) - and suggests
that greater success rates can be achieved if women are offered the
PelvicToner(TM) to encourage a more effective and sustained exercise regime.

The PelvicToner(TM) is a registered medical device that works by
strengthening the pelvic floor muscles through mild resistance training.
This gives greater bladder control when coughing, sneezing, laughing or
exercising.

Researchers at the Bristol Urological Institute (BUI) said the
PelvicToner(TM) was "easy to use" and proved "particularly helpful" in the
majority of cases. 86 per cent of participants who used the PelvicToner(TM)
reported a "significant" improvement in their condition.

The PelvicToner(TM) is on sale priced GBP29.99, but could become
available on NHS prescription. According to Professor Drake, who led the BUI
study, it could supplement current NHS treatments and provide a long-term
solution to stress incontinence.

He said: "The PelvicToner(TM) aided women in identifying their pelvic
floor confidently. It increases patient choice and may promote subsequent
compliance and sustained efficacy."

    Key points noted by the research are that the PelvicToner(TM):

    - gives "confidence to women that they were correctly contracting
      their pelvic floor."

    - the biofeedback given can "demonstrate to the woman that she is
      carrying out the PFME appropriately."

Professor Drake noted that the PelvicToner(TM) is particularly relevant
to those women "who do not consult their physician and wish to maintain
confidentiality regarding their SUI symptom."

Stress incontinence occurs as a result of reduced support for the
bladder, usually by 'sagging' pelvic floor muscles. This is commonly
brought-on by childbirth and menopause but a life-long lack of effective
pelvic floor exercise and obesity are also major factors.

According to Professor Drake, exercises recommended by the NHS often
fail to help because of inadequate training, slow improvement or a lack of
patient commitment.

Other forms of treatment include electrical stimulation, drugs and
Surgery, but most women rely on the use of absorbent pads which are
expensive and environmentally unsound.

According to SPM, the device's Bristol-based manufacturer, a major
benefit of the PelvicToner(TM) is the speed of improvement compared to
pelvic floor exercise alone. An independent survey carried out by SPM found
87 per cent of users had better bladder control within four weeks, compared
to the several months expected following the NHS regime.

Barry Fowler, who developed the PelvicToner(TM), said: "We believe that
the PelvicToner(TM) can significantly improve the service and treatment that
women receive from the NHS and help the NHS save a great deal of money by
making the preferred treatment option more effective."

"Millions of women are still too embarrassed to even consult with their
doctor because of the taboo that surrounds stress incontinence. For these
women especially, help is now immediately at hand with a medical device that
is accessible, cheap, simple to use and of proven effectiveness."

The PelvicToner can be purchased from www.pelvictoner.co.uk or
from +44(0)117-968-1414

There is comprehensive information with links to the British Journal
of Urology article on www.pelvictoner.co.uk and
www.mypelvicfitness.com.

For further information contact Barry Fowler at press at spml.biz or +44(0)117-968-0171.